GPT and obesity disorder: Therefore, there has been increasing interest in identifying bioactive compounds that have potential for reducing triglyceride, non-HDL cholesterol, GPT and GOT and also enhancing adiponectin levels to help manage obesity and its associated metabolic diseases.